| Just Other Articles |
Hubs | Hubbers | Topics | Request |
| #1 in Business | Subscribe Email Print |
|
You are here: Home > Business > Business > Leadership Development - Secure The Future |
|
Just Other Articles - Leadership Development - Secure The Future
“At senior levels of an organization, the ability to adapt, to make decisions quickly in situations of high uncertainty, and to steer through wrenching change is critical. But at a time when the need for superior talent is increasing, big U.S. companies are finding it difficult to attract and retain good people. Executives and experts point to a severe and worsen According to USFDA, a combination product is one composed of any combination of a drug and device; biological product and device; drug and biological product ing shortage of the people needed to run divisions and manage critical functions, let alone lead companies. Everyone knows organizations where key jobs go begging, business objectives languish, and compensation packages skyrocket.” Elizabeth Chambers etal, McKinsey & Company, The War for Talent In a recent interview, Dr. Jay Conger states, “Business organization ; or drug, device, and biological product and fixed dose combination would include two or more combinations of drug. Examples of combination products may in s are not designed to be great training grounds for leadership development. They are great training grounds for execution of an existing business model and, if [the business model is] right, all you need are managers. The problem is that every few years that business model comes under attack and, when it does, you need leaders. Now the problem is that you haven’ lude drug-coated devices, drugs packaged with delivery devices in medical kits, and drugs and devices packaged separately but intended to be used together. t been developing them, so you get blown out of the water.” (“Why Chief Executives Fail,” May 2003, Management Today) As faithful readers know, I’ve had the pleasure and honor to meet some of the world’s greatest leaders and leadership gurus from Sir Richard Branson, General Tommy Franks, and Captain Mike Abrashoff to Dr. Warren Bennis, Dr. Henry Mintzberg, Tom P here is enormous increase in the number of combination products entering the market in the recent years. Combination products have proven advantages but fixe ters, and most recently Dr. Jay Conger. Through our work with Linkage Inc., we help support broadcasts of these famous people by designing and developing participant and facilitator guides that many clients use to turn a 90-minute presentation into a true learning and growth opportunity. I recently had the opportunity to meet with Dr. Jay Conger to discuss the to d dose combinations are still in the process of convincing regulatory authority on their advantages over the single ingredient formulations. Combination pro pic of leadership development and succession planning. Dr. Conger has found that companies who are successful at identifying and developing leadership talent address each of the following key components: • Sponsorship – personal, active, and regular involvement at the highest levels. • Selection – matching capabilities with organizational needs; avoiding complex ucts have become life saving products for the pharmaceutical companies who doesn’t have many innovative molecules in their product pipeline and have been inc competency models; acknowledging and addressing things that will derail a potential leader. • Assessors – objectively and subjectively measuring performance and results. • Participants – engaged and personally committed potential leaders, resulting in greater self-direction and organizational loyalty. • Development linkages – using stretch goals and a myriad of easingly used in the product life cycle management. Even the companies having product patents are trying to extend their product life cycle through the combi assignments, participants are being developed – not merely identified – for succession in a purposeful and planned manner. • Tracking – measuring the effectiveness of the leader – and the leadership selection and development process – to ensure continual improvement in developing the leadership bench. In his book, Growing Your Company’s Leaders: How Great Organiz nation products and maximize the revenues. But the companies involved in this practice are overlooking that they are burdening the patients both economically ations Use Succession Management to Sustain Competitive Advantage, Dr. Conger outlines the characteristics of companies who are winning the war for talent through their leadership development systems. These characteristics include: First, the most effective systems are simple and easy to use. All participants – not just those running the systems but candidates a and physically. They need to rightly judge the benefits of the combination products and they have to even look at the risks involved when combining the produ s well – have easy access to them. Data is secure but open to those who need it. The winning systems are nonbureaucratic, uncomplicated processes. As an element of that simplicity, there is a unified approach to succession management to ensure consistency and to maintain objectivity of succession management between different business units, organizational levels ts. Some of the combination products were well accepted by physicians while others suffered. Companies involved in development of combination products are fi and geographic areas. Second, the best systems are developmentally oriented rather than simply focused or replacement oriented. System processes are clearly more concerned with the continuing growth and development of the employee than with an ultimate job title. They introduce a discipline into the organization that continually reminds everyone that leadership ding difficulty in defining their combination products and facing various challenges from selecting a combination to marketing it. Following aspects would a development and talent retention are critical priorities and every manager’s responsibility. The system becomes a proactive vehicle for managers and executives to reflect on the progress of their talent and the opportunities they require for genuine development. Third, highly effective systems always actively involve the very top players of the organization. Th dd to the challenges in developing combination products: Which markets to tap where the combination products can do fairly well? Which combination prod e CEO and the executive team are committed sponsors and champions-proactively participating in determinations of talent and in “next steps” to ensure the maximum development of their talented employees. Effective succession management is seen as a critical strategic tool by senior executives for attracting and retaining their most talented leaders. Fourth, best p cts are meaningful and rational? Which therapeutic categories to select? Which Combinations can address unmet needs of the patients? Do combin ractice succession systems are effective at spotting gaps in talent and at identifying important “linchpin” positions. They highlight existing or emerging needs where there are potential shortages of talent within the firm. They focus intensively on linchpin positions-a select set of jobs that are critical to the overall success of the organization. These positi tions increase the patient compliance? What would be the developing cost? How to tackle the risks encountered during combination product developmen ns and the individuals who fill them merit and receive regular and intensive attention. The better systems also identify the best jobs for development and whether there are a sufficient number of these or shortages. Fifth, succession planning still does the job of monitoring the succession process, enabling the company to make certain that the right people are mo t? As combination products don't fit into the traditional categories of drugs, medical devices, or biological products, the USFDA is in the process of devel ving into the right jobs at the right time and that gaps are being spotted early. The best systems incorporate frequent checkpoints throughout the year. These checkpoints monitor who is where and where the person should be going next. A checkpoint function is built into the system to spot a problem before it becomes a problem! Succession management is so import ping new procedures for reviewing their safety, efficacy and quality. Professional from academic institutions, pharmaceutical industries, health care indust ant that the best practitioners don’t ignore this function for even a quarter. Finally, the most successful systems are built around continual reinvention. One of the clearest insights from our research is that effective succession management is a journey, not a destination. Best practice companies did not succeed in their first efforts at succession management. y and representatives from various regulatory agencies are working out to design the regulatory requirements for manufacture and sale of combination products Similarly, none have rested on their laurels since having their process up and running. They continually refine and adjust their systems as they receive feedback from line executives and participants, monitor developments in technology, and learn from other leading organizations. To avoid the ever-present danger of becoming bureaucratized and mechanical, best pra . As there is an increasing trend of the combination products companies manufacturing such products should be able to tackle the problems involved in the de ctice systems therefore actively incorporate dialogues and debates about talent and about the succession process. There are continuous “conversations” about what is needed for the future of each candidate, about who should be where, and when. There are continuous conversations on the part of the guardians and designers about the planning process and how its utili elopment. They need to be wiser in analyzing the market trends and the regulatory requirements. Companies that provide selfless information through particip zation can be improved. (Growing Your Company’s Leaders, pp 12-15) Leadership Development/Succession Planning Capability Scorecard Entelechy has created a Leadership Development/Succession Planning Scorecard based on Dr. Jay Conger’s research to help you determine the strength of your company’s (or department’s) succession planning/leadership development process tion in industry events and feedback to regulatory authorities would be able to face the challenges and will be successful in developing combination products
HTTP = HTML link (for blogs, profiles,phorums):
Related Articles:Time Management - Making the Most out of a Limited Resource
|